Indolequinoxalines Derivatives – Promising Compounds with Antiviral and Interferon Inducing Actions
DOI:
https://doi.org/10.20535/1810-0546.2016.3.68691Keywords:
Interferon inducers, Antiviral activity, Vesicular stomatitis virus, Interferon-inducing action, Amiksin, Derivatives of indolohinoksalinAbstract
Background. The development of new drugs with antiviral activity and the ability to induce interferon is an urgent task, taking into account the rapid spread of viral infections, development of resistance the virus strains to existing antiviral drugs and the overall decline of the immune response.
Objective. Determine the antiviral activity and interferon inducer actions of indolequinoxalines derivatives in terms of in vitro.
Methods. The work on PST cell cultures in conditions of in vitro antiviral and interferon inducer of the 18 new indolequinoxalines derivatives was studied.
Results. The ability of indolequinoxalines derivatives to inhibit the development of viral cytopathic effect on the model PST-BBC only in therapeutic regimens was shown. In the model of inoculated cell cultures PST is shown that 12 compounds are capable of inducing interferon in low concentrations.
Conclusions. Among the indolequinoxalines derivatives RG-61 compound as a promising for further studies was identified, which has a low toxicity (as compared to a number of compounds derived), has antiviral activity in infected cells and is capable of inducing IFN.
References
N.Ya. Spivak et al., “Interferon inductors as antiviral agents: new aspects of an old problem”, Zhurnal Orhanichnoyi ta Farmatsevtychnoyi Khimiyi, vol. 5, iss. 1 (17), pp. 4–20, 2007 (in Ukrainian).
F.I. Yershov, Interferon System in Health and Disease.Moscow,Russia: Meditsina, 2006 (in Russian).
F.I. Yershov, “Guidelines for the study of the specific activity of interferon and interferon inducers”, in Guidance on Observational (Non-Clinical) Study of New Pharmaceutical Substances.Moscow,Russia: Remedium, 2000, pp. 281–286 (in Russian).
“Design, synthesis and structure-property relationship in several interferon-inducing ligand and antiviral DNA”, A.V. Bogatsky Physico-Chemical Institute of NAU, Odesa, Ukraine, Res. Rep. 0104U004313, 2006 (in Ukrainian).
Preclinical Research of Medicines, O.V. Stefanova, Ed. Kyiv. Ukraine: Avicena, 2001 (in Ukrainian).
A.E. Medvedev et al., “A study of the action of immunosuppressive factors from tumour cells on lymphocytes and macrophages in vitro and on the graft-versus-host reaction in mice”, Biomed. Sci., vol. 1, no. 3, pp. 261–266, 1990.
L.N. Lazarenko et al., HPV Infection and Interferon System. Kyiv, Ukraine: Fitosotsiotsentr, 2008, pp. 237–238 (in Russian).
D.A. Novikov and V.V. Novochadov, Statistical Methods in Biomedical Experiments (Typically). Volgograd, Russia: Izd-vo VolGMU, 2005 (in Russian).
Downloads
Published
Issue
Section
License
Copyright (c) 2017 NTUU KPI Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under CC BY 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
